🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with numerous of members share “before and after” images, injection guides and claims of rapid UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, doctors and chemists have warned that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.

Some experts stated the demand for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, advertising, and consumer laws, potentially leading to fines, prosecution or prison.

Service Reaction and Content Removal

According to the social media company, the service has taken down violative material and banned related keywords and query recommendations. The company said it was committed to maintaining the service secure and investing in strengthening enforcement strategies.

Online Trading Activities

Investigations also found groups with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, positive testimonials and step-by-step instructions for mixing or administering at home.

After moments of joining one group, a seller shared WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Item Details and Pricing

Within these groups, posts show black plastic parcels with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how long a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram stated it actively monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they cannot confirm. Even if the science behind this drug is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the increase in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are using online platforms. But fake treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has previously seen patients harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to potentially significant health risks”.